Kia UP

On November 21, 2022, the MDA has announced the release of the Fourth Edition Guidance Document “Change Notification for Registered Medical Device” (MDA/GD/0020). This guidance document is a revision from the Third Edition that was issued in November 2018, to provide the medical device industry a guidance on the categories of changes, the principles of

On November 21, 2022, the MDA has announced the release of the Sixth Edition Guidance Document “Requirements for Labelling of Medical Devices” (MDA/GD/0026). This guidance document provides minor updates from the Fifth Edition that was issued on 14 June 2022. This document provides guidance to the manufacturers and authorized representatives on the content of medical

On September 15 2022, the MDA has issued second edition of guideline document entitled “Re-Registration of Registered Medical Device” (MDA/GL/08). The following information are added on the guideline: Applicant is not allowed to submit re-registration application concurrently with change notification application; and Requirements on Pre-Market Clearance / Approval All application shall undergo conformity assessment via

On September 23 2022, the MDA has announced the release of the Second Edition Guidance Document “Licensing for Establishments” (MDA/GD/0027). This guidance document was prepared by the Medical Device Authority (MDA) to help the industry and healthcare professionals in their quest to comply with the Medical Device Act (Act 737) and the regulations under it.

MDA has released a new guideline document for the registration of Orthopoxvirus (Monkeypox) IVD Test Kits, entitled “Guideline for Registration of Orthopoxvirus (Monkeypox) IVD Test Kits” (MDA/GL/09), First Edition” dated September 2022. The guidance document entails the registration requirements, registration process flow, classification, evaluation timeline, application and registration fees of Orthopoxvirus (Monkeypox) IVD Test Kits.

On September 5th 2022, the MDA released two First Edition Guidance Document: “Harmonized Classification of Medical Devices In ASEAN” (MDA/GD/0062) and the First Edition Guidance Document: “Harmonized Borderline Products in ASEAN” (MDA/GD/0063). These guidance documents are mostly concerned with: Harmonized list of risk classification of medical devices including in-vitro diagnostic (IVD) medical devices based on

The Medical Devices Authority (MDA) has joined Operation Pangea XV from June 22 to July 05, 2022, which is a worldwide campaign operation to carry out large-scale enforcement actions against the sale of counterfeit and illicit medicines and medical products. This operation is coordinated by the International Criminal Police Organization (Interpol) with the involvement of

On July 14th 2022, the MDA announced Medical Device Centralized Reporting System (Medcrest) is ready to be used by an establishment of a medical device. All Mandatory Problem Reporting, Field Corrective Action and Device Recall can be done online using the Medcrest system starting July 15th, 2022. This new system can be accessed through the

MDA would like to inform that the Medical Device (Responsibility & Establishment) Regulations 2019 will be fully enforced, effective July 1, 2022. With the full enforcement of these rules, it means that all parties involved in the importation, distribution, and placement of medical devices in the market are required to comply with all the post-market

On 22 June 2022, Malaysia’s Medical Device Authority (MDA) has released The Fifth Edition Guidance for Labeling on Registered Medical Devices. The purpose of the document is to provide guidance to manufacturers and authorised representatives on the content of medical device labelling. This amendments from the fourth edition to fifth edition are as follows: Clause

The MDA has informed the public that they will give transition period until 31 December 2022 to the establishment for compliance with the requirements set out in the guidance document “Requirements for Labelling of Medical Devices (MDA/GD/0026), Fifth Edition”. To ensure that the importation and distribution of medical device could be carried out smoothly, the